3-arylisoquinolinamine derivative
Product Specifications
UNSPSC Description
3-arylisoquinolinamine derivative is a 3-arylisoquinolinamine derivative with antitumor activity.
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/3-arylisoquinolinamine_derivative.html
Purity
99.42
Solubility
DMSO : ≥ 50 mg/mL
Smiles
NC1=NC(C2=CC=CC(OC)=C2)=CC(C=C3)=C1C=C3N(C)C
Molecular Weight
293.36
References & Citations
[1]Yang SH, et al. Synthesis, in vitro and in vivo evaluation of 3-arylisoquinolinamines as potent antitumor agents. Bioorg Med Chem Lett. 2010 Sep 1;20(17):5277-81.|[2]Young Bok Lee, et al. 5, 6, or 7-substituted-s- (hetero)arylisoquinolinamine derivatives as antitumor agents. WO 2008063548 A2.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-32364/3-arylisoquinolinamine-derivative-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-32364/3-arylisoquinolinamine-derivative-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1029008-71-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MPX4201K Each
Magic™ Membrane Protein Human CHRNA7 (Cholinergic receptor nicotinic alpha 7 subunit) Expressed in E.coli with 6xHis tag at the N-terminus for Antibody Discovery, PaRoom Temperatureial (23-230aa)
Ask
View Details 
YR0173-01 5 mg
In Vivo Grade Recombinant Mouse IgG2c Isotype Control Antibody, Endotoxin 0.05 EU/mg
Ask
View Details 
YR0173-02 25 mg
In Vivo Grade Recombinant Mouse IgG2c Isotype Control Antibody, Endotoxin 0.05 EU/mg
Ask
View Details